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1. Introduction 
In the 21st century, despite advanced diagnostic imaging, improved antibiotic treatment, and 
widely available surgery, the incidence of infective endocarditis (IE) has not reduced in 
recent years, and continues to have high morbidity and mortality (Prendergast, 2005). Over 
the years there have been changes in the natural history, predisposing factors, sequelae and 
causative organisms. In particular, rheumatic heart disease is an uncommon predisposing 
factor, and now degenerative valve disease is much more common in the elderly 
population. As with many conditions, elderly patients with IE can present in very non-
specific ways, making diagnosis more difficult, leading to delays in treatment. IE in elderly 
patients is associated with a poor prognosis. Fewer patients receive valve surgery, due to 
higher operative risk, but this does still remain a treatment option for suitable patients. Our 
knowledge and understanding of endocarditis in the elderly, compared to younger patients, 
is predominantly influenced by important case series reports in the literature (Table 1) and 
these will be referred to in the text. European Guidelines are available for guidance in 
management of IE in all age groups (European Society of Cardiology, 2009). 
2. Epidemiology 
Elderly patients are predisposed to infectious diseases for multiple reasons; impairment of 
innate and adaptive immunity, increased comorbidities, increased functional limitations, 
increased instrumentation and implantation of prosthetic devices, and increased numbers of 
patients living in care homes (High et al, 2005). These factors result in an increase in adverse 
outcomes in the elderly. It therefore stands to reason that the incidence of IE has been shown 
to increase with age, and the incidence amongst elderly patients is also increasing (Dhawan, 
2002). So with the ageing population, IE in the elderly is at an all time high. In the European 
Heart Survey, 26% of cases of IE were in elderly patients (>70 years old) (Iung et al, 2003), 
and in a French survey 33% of IE patients were over 67 years of age (Delahaye et al, 1999). In 
further French studies, the incidence of IE peaked between the ages of 70 and 80 years 
(Hoen et al, 2002). The risk of IE in the elderly has been found to be 4.6 times higher than in 
the general population. Reasons for this may include a high prevalence of undiagnosed 
degenerative valve disease, and again higher rates of invasive procedures and implanted 
devices compared to younger patients. 
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pacemakers or valves) 
Causes    
Selton-Suty 
et al (1997)      
Total               114    
Over 70            25 
Under  70         89 
Younger patients more embolic 
complications 28% v 8% (p< 0.05) 
52% elderly v                  
25% young                      
(p< 0.05) 
Portal of entry 
more often 
digestive in older 
patients  50% v 
17% (p=0.01) 
Di Salvo    
et al (2003) 
Total               315 
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50-70               111 
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Clinical features similar between 3 
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patients under 50 years 
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but prosthetic valve 





urinary portal of 
entry 
Durante-
Mangoni   
et al (2008) 
Total             2759 
Over 65        1056 
Under 65      1703 
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vegetations and more abscesses in older 
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including diabetes and cancer, 
commoner in older people. Rate of 
complications lower in older people. 
More commonly 
prosthetic devices or 
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It has been previously reported that IE in the elderly is associated with a poor prognosis and 
high complication rate. The onset is usually insidious, sometimes the presenting symptoms 
are less severe, and diagnosis is sometimes therefore delayed, as well as more aggressive 
pathogens causing the infection. Age has been shown to be an independent prognostic 
factor for in-hospital mortality (Durante-Mangoni et al, 2008). 
3. Causes 
Historically, previous rheumatic heart disease was a very common predisposing factor for 
IE (Prendergast, 2005). However, this is now rarely a factor. Older people are particularly 
prone to develop mitral annular calcium (MAC). This is a chronic degenerative process 
that occurs in older persons, particularly women, and often results in mitral regurgitation 
(Roberts and Perloff, 1972). Older people with MAC have a high incidence of atrial 
fibrillation and are especially at risk of developing endocarditis (Mambo et al, 1978). The 
avascular nature of the mitral annulus prevents antibiotics reaching the bacteria, 
predisposing to peri annular abscesses and a poor prognosis. Aronow et al (1990) 
demonstrated at follow up of 39 months a 3% incidence of bacterial endocarditis in 526 
older persons with MAC and only a 1% incidence in 450 older persons without MAC. In 
IE in the elderly, gastrointestinal sources of bacteria are more common. Group D 
streptococcus (Streptococcus bovis) is frequently implicated (Vahanian, 2003). This is 
associated with colonic pathology, in particular neoplasia, as well as the involvement of 
multiple valves and embolic complications. Enterococcus is also more common in the 
elderly. However, it has also been reported that vegetations in the elderly are generally 
smaller, with a lower embolic risk (Selton-Suty et al, 1997). Pathogens are more commonly 
of urinary origin as well. It is thought that this is due to the higher proportion of urethral 
and prostatic procedures performed in the elderly (Di Salvo et al, 2003). Pacemaker 
endocarditis is commoner amongst the elderly, as would be expected as the number of 
patients with pacemakers increases with age (Remadi et al, 2009). Pacemaker endocarditis 
has been associated with even more difficult and delayed diagnosis, resulting in a poor 
prognosis.  
4. Diagnosis 
The clinical diagnosis of IE is based on Duke criteria, which includes positive blood cultures, 
suggestive features on echocardiography, predisposing heart disease, fever, and vascular 
and immunological phenomena (Prendergast, 2005). The St Thomas modifications include 
serology, elevated inflammatory markers, and other clinical signs including splenomegaly, 
haematuria, splinter haemorrhages and rashes (Prendergast, 2005). However, the onset of IE 
can be acute or insidious, and the presence of classical signs as described by Duke criteria 
are often absent, particularly in the elderly (Vahanian, 2003). Therefore, in the presence of 
signs of sepsis with no obvious source, IE should always be considered in the elderly. Table 
2 lists the many common presentations in older people. Overall, the elderly report fewer 
symptoms (Selton-Suty, 1997). Fever is less common than with younger patients, but 
anaemia is more common, probably due to the presence of Streptococcus bovis and colonic 
pathology, resulting in bleeding and anaemia. Delirium is also a more prominent feature. 






suspicion of IE. New or changing murmurs are heard less frequently in the elderly. Positive 
blood cultures remain the main diagnostic tool (Prendergast, 2005). At least three sets of 
cultures should be taken prior to the administration of any antibiotics, and ideally both 
aerobic and anaerobic cultures should be incubated. Negative cultures most frequently 
occur after prior antibiotic administration, but increasingly due to fastidious organisms. In 
particular, negative cultures occur in IE related to prosthetic valves and pacemakers, which 
are more common in the elderly. Transthoracic and transoesophageal echocardiography 
(TTE and TOE respectively) are now commonly used in the diagnosis and management of 
IE (Prendergast, 2005). It has been reported that the detection of vegetations in the elderly is 
lower with TTE, so TOE should be used as it is more sensitive and specific. In general, TTE 
is performed first, then TOE performed when TTE is negative, but there is a high clinical 
suspicion of IE. TOE has revolutionised the diagnosis of IE in the elderly by increasing the 
diagnostic yield by 45% (Dhawan, 2002). 
Sepsis of unknown origin (especially if associated with known infective 
endocarditis causative organism). New regurgitant murmur. Embolic events of 
unknown origin. Fever if associated with: 
- Intracardiac prosthetic material, including pacemakers 
- Previous valvular heart disease 
- Congestive cardiac failure 
- Recent medical interventions with bacteraemia New cardiac conduction 
disturbance 
- Positive blood cultures with IE causative organism 
- Peripheral abscesses of unknown cause 
- Non specific neurological symptoms or signs 
- Previous history of IE 
Table 2. Clinical presentations of infective endocarditis in the elderly 
5. Management 
Successful treatment of IE in the elderly requires close cooperation between the geriatrician, 
cardiologist, microbiologist, and cardiac surgeon. Regular review of the patient is required 
to assess for progression or development of complications (Prendergast, 2005). International 
guidelines have been published to provide recommendations on the treatment of IE 
(European Society of Cardiology, 2009). Rapid administration of antibiotics is critical in the 
initial management of IE (Dhawan, 2002). Antibiotics in high serum concentrations are 
essential to ensure penetration into the vegetations, and prolonged treatment (4-6 weeks) is 
required to kill dormant bacteria (Prendergast, 2005). Intravenous antibiotics as an in-patient 
is the preferred method, but with increasing provision for the administration of intravenous 
antibiotics in the community, this is becoming an increasingly popular option after the 
initial two week treatment period when the complication rate is highest. However, this may 
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not be a suitable option in elderly patients who may require in-patient care for the full 
duration of treatment. Usual initial treatment is broad spectrum, with a combination of a 
penicillin and an aminoglycoside. In the presence of a prosthetic valve vancomycin or 
gentamicin is usually used, with or without rifampicin (Dhawan, 2002). There is no evidence 
for the use of oral antibiotics after the completion of the intravenous course (Prendergast, 
2005). When IE is suspected, and after blood cultures have been taken, broad spectrum 
intravenous antibiotics should be administered until the results of the cultures and 
sensitivities is known, then a more specific antibiotic can be commenced (Prendergast, 2005). 
Prosthetic valve and pacemaker endocarditis, which is more common in the elderly requires 
4-6 weeks of intravenous antibiotics, as well as removal of the prosthesis if possible 
(Prendergast, 2005). Repeat valve surgery is recommended in early prosthetic valve 
endocarditis. Surgery can be life saving in cases of IE and has been shown to be of benefit in 
suitable elderly patients. Often elderly patients are more unwell with multiple comorbidities 
and therefore may be deemed unsuitable for surgery (Prendergast, 2005). In one study (Di 
Salvo et al, 2003) surgery was performed only slightly less frequently than in younger 
patients and the operated group had a lower mortality. Of course this may reflect the fact 
that the patients suitable for surgery are generally fitter. Elderly patients may also refuse 
surgery. In a recent study of 961 patients with endocarditis in Spain (Ramírez-Duque, 2011) 
significantly fewer elderly patients underwent cardiac surgery (Table 1). The three main 
indications for surgery are heart failure, uncontrolled infection, and prevention of embolic 
events (European Society of Cardiology, 2009). In the Spanish study (Ramírez-Duque, 2011), 
compared with medical treatment, surgery showed lower mortality in the younger patients 
(less than 65 years), but a high mortality was observed with both medical and surgical 
treatment in the elderly (over 65 years). Overall in Europe, surgery is undertaken in around 
50% of patients with IE with long-term survival rates of around 70% (Prendergast and 
Tornos, 2010). Surgery is better undertaken early before cardiac tissue damage has occurred 
and there is a general deterioration in the patients condition. Delay in surgery may 
contribute to poor outcomes in older patients. 
6. Culture negative endocarditis in the elderly 
Culture negative endocarditis is particularly common in older patients. The definition of 
culture negative endocarditis is endocarditis which fulfils established diagnostic criteria 
for endocarditis, but at least three independent blood cultures are negative after seven 
days of incubation and subculturing (Raoult et al, 2005). A two year multicentre 
prospective study in Italy found that 25% of patients with a definite diagnosis of 
endocarditis by Duke criteria were culture-negative (Cecchi et al, 2004). Cultures are 
negative in endocarditis for three major reasons: i) previous administration of antibiotics; 
ii) inadequate microbiological techniques, or iii) infection with highly fastidious bacteria 
or non-bacterial pathogens (e.g. fungi). Risk factors for culture negative endocarditis 
include underlying valvular heart disease, presence of a pacemaker and exposure to 
fastidious organisms. HACEK organisms (Haemophilus aphrophilus; Actinobacillus 
actinomycetemcomitans; Cardiobacterium hominis; Eikenella corrodens and Kingella 
Kingae) were originally thought to be the most common cause. However, better 






a prospective study of 348 patients with culture negative endocarditis 275 (79%) 
aetiological agents were identified using serological tests, and polymerase chain reaction 
(PCR) techniques (Houpikian and Raoult, 2005). The commonest agents found were 
coxiella burnetti (Q fever) and bartonella species. Serology and PCR on blood samples or 
removed valves can therefore help considerably in identifying fastidious organisms. 
Fungi are particularly common pathogens in early prosthetic valve endocarditis (Thuny et 
al, 2010). Clinically if it is not possible to identify the aetiological agent then treatment 
may have to be directed either at the most likely source if the patient has already been on 
antibiotics, or as broad spectrum as possible while closely monitoring clinical response. 
The long-term prognosis of negative blood culture IE in the elderly is similar to patients 
with positive blood cultures (Peréz de Isla et al, 2007). A specific form of culture negative 
endocarditis can occur in older people and cause diagnostic uncertainty. Non-bacterial 
thrombotic endocarditis (NBTE), or marantic endocarditis, is a rare condition associated 
with cancer and other illnesses where there is an increased thrombotic tendency, for 
example septicaemia (Clough et al, 2010). Clinical features of NBTE are very small, 
multiple valvular vegetations which may be only visible on TOE and multiple small, 
medium and large disseminated emboli in patients with an underlying cause for NBTE , 
and multiple negative blood cultures and serology. NBTE, unlike IE, may benefit from 
anticoagulation, but the outlook is poor, usually because of the underlying cause. 
7. Complications and outcomes of infective endocarditis in the elderly 
Complications of infective endocarditis can be categorised as:  
i. cardiac;  
ii. septic;  
iii. embolic;  
iv. neurological;  
v. musculoskeletal;  
vi. renal;  
vii. associated with medical treatment.  
Cardiac complications are the most common complication in older patients. The most 
common of these is heart failure which is also the most common cause of death in IE. The 
usual cause of heart failure is infection-induced valvular damage for which cardiac surgery 
may be lifesaving. Embolisation seems less common in older people (Selton-Suty, 1997), but 
can occur resulting in stroke, splenic or renal infarction or myocardial infarction. The risk of 
embolisation is reduced by prompt antibiotic therapy. Apart from embolic stroke, other 
neurological complications include brain abscesses, seizures, meningitis and encephalitis. 
Renal failure may result from renal infarction, but also from glomerulonephritis and rarely 
renal abscesses. Musculoskeletal complications include vertebral osteomyelitis or discitis 
and septic arthritis. Finally, older patients with IE can develop complications associated 
with prolonged antibiotic treatment – for example ototoxicity and nephrotoxicity. It is 
widely accepted that age is an independent predictor of mortality in IE (Durante-Mangoni et 
al, 2008). Other factors associated with poor outcome are listed in Table 3 and include 
diabetes, significant comorbidities, heart failure and echocardiographic findings of poor left 
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ventricular function, severe valve regurgitation and large vegetations. However, prognostic 
predictions should be made with caution in individual patients and many of these factors 
may be correctable with surgery. 
8. Prevention of endocarditis in the elderly 
It has previously been recommended that antibiotic prophylaxis should be given to the 
majority of patients with congenital and valvular heart disease before any dental or surgical 
procedure. However, this recommendation has now been narrowed to only high risk 
patients, including patients with prosthetic heart valves or with a previous history of IE and 
only for high risk procedures. High risk procedures include dental procedures that involve 
manipulation of gingival tissue, or the peri-apical region of the teeth, or perforation of the 
oral mucosa and also procedures in patients with ongoing gastrointestinal or genito-urinary 
infections. Interestingly, the NICE guidelines for England and Wales do not advocate 
antibiotics, even for high risk patients undergoing dental procedures (Chambers et al, 2011). 
This is because of lack of convincing trial evidence for antibiotic prophylaxis, even in this 
high risk group, and the risk of anaphylaxis with antibiotics and the potential development 
of antibiotic resistance. However, this is contrary to the European guidelines (European 
Society of Cardiology, 2009) and the usual practice of most clinicians who are influenced by 
the high mortality rate of high risk patients if they develop endocarditis, even though it may 
be a rare complication. 
Older age Prosthetic valve endocarditis Diabetes Comorbidity (frailty, renal or 
pulmonary disease) Complications  
- heart failure 
- renal failure 
- stroke 
- septic shock Infecting organisms 
- staphylococcus aureus 
- fungi 
- gram negative bacilli Echocardiographic findings 
- large vegetations 
- pulmonary hypertension 
- periannular complications 
- poor left ventricular ejection fraction 
- severe left sided valve regurgitation or severe prosthetic dysfunction 
Table 3. Predictors of poor outcome in older patients with infective endocarditis 
9. Conclusion 
IE is a very important and atypical illness in older people. Firstly, its incidence seems to be 
increasing because of the increase in degenerative valvular disease and the increasing use of 






on the underlying cardiac disease and the microorganisms involved and the underlying 
patient comorbidities and resistance to infection. It therefore requires a collaborative 
approach involving physicians, geriatricians, cardiologists, cardiac surgeons and 
microbiologists. Thirdly, the evidence for its clinical manifestations, treatment and 
prognosis comes from clinical case series rather than from clinical trials or meta-analyses. 
Five important case series predominantly from Europe have been published and are 
summarised in Table 1, comparing older patients with younger patients with IE. 
Consistently older patients tend to have a higher mortality, are less likely to have surgery 
and more likely to have prosthetic devices and be infected with bacteria from the gut or 
urinary tract. Older people are more likely to present insidiously with smaller vegetations 
and less embolic manifestations. It can be argued that IE is a completely different disease in 
the older person and deserves a different, more aggressive approach in both treatment and 
prevention because of its high morbidity and mortality. 
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